D. Giesen

No picture available
E-mail:
d.giesen umcg.nl

Research

Publications
  1. 89Zr-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors

    Giesen, D., Broer, L. N., Lub-De Hooge, M. N., Popova, I., Howng, B., Vasiljeva, O., de Vries, E. G. E. & Pool, M., Feb-2019, In : Annals of Oncology. 30 , Suppl 1, p. i4 1 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Probody therapeutic design of 89Zr-CX-072 promotes accumulation in PD-L1 expressing tumors compared to normal murine lymphoid tissue

    Giesen, D., Broer, L. N., Lub-de Hooge, M. N., Popova, I., Howng, B., Nguyen, M., Vasiljeva, O., de Vries, E. G. E. & Pool, M., 17-Jan-2020, In : Clinical Cancer Research. 40 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Zr-89-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors

    Giesen, D., Broer, L. N., Lub-De Hooge, M. N., Popova, I., Howng, B., Vasiljeva, O., de Vries, E. G. E. & Pool, M., Feb-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  4. Theranostics Using Antibodies and Antibody-Related Therapeutics

    Moek, K. L., Giesen, D., Kok, I. C., de Groot, D. J. A., Jalving, M., Fehrmann, R. S. N., Lub-de Hooge, M. N., Brouwers, A. H. & de Vries, E. G. E., Sep-2017, In : Journal of Nuclear Medicine. 58, Suppl 2, p. 83S-90S 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (6) »

ID: 28577992